Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Patent
1997-06-25
1999-11-09
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
424464, 514456, 514453, 514882, A61K 948
Patent
active
059809388
ABSTRACT:
The present invention provides methods of inhibiting PAI-1 using benzopyrans.
REFERENCES:
patent: 4418068 (1983-11-01), Jones et al.
patent: 5446061 (1995-08-01), Bryant et al.
Sawa et al, Potentiation of hypercholesterolemia of the induction of aortic intramural synthesis of plasminoggen activator inhibitor type I by endothelial injury, Circulation Research, 671-680, 1993.
Uchiumi, et al., Int. J. Cancer, 47(1): 80-85 (1991).
Dickerman, et al., Endocrinology, 125: 492-500 (1989).
Juhan-Vague, et al., Ann. Biol. Clin., 45: 202-206 (1987).
Sharma, et al., J. Med. Chem., 33(12): 3216-3222 (1990).
Shatos, et al., Circulation, 94(4):636-642 (1996).
Biemond, et al. Clin. Sci., 88(5):587-594 (1995).
Marsh, et al., Circulation, 90(6): 3091-3097 (1994).
Hamilton, et al., Cell-Immunol., 152(1): 7-17 (1993).
Berg David Thompson
Cullinan George Joseph
Grinnell Brian William
Richardson Mark Alan
Boudreaux William R.
Channavajjala Lakshmi
Eli Lilly and Company
Page Thurman K.
Sales James J.
LandOfFree
Effect of compounds that suppress induction of plasminogen activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Effect of compounds that suppress induction of plasminogen activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effect of compounds that suppress induction of plasminogen activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1452169